Home › Asset managers › Guggenheim › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Guggenheim voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,496 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Guggenheim voted | Funds |
|---|---|---|---|---|---|---|---|
| Sutro Biopharma, Inc. | June 6, 2025 | Election of Class I Directors: Heidi Hunter | Director Elections | Board | WITHHOLD | 5 | |
| Sutro Biopharma, Inc. | June 6, 2025 | Election of Class I Directors: Jon Wigginton, M.D. | Director Elections | Board | WITHHOLD | 5 | |
| Sutro Biopharma, Inc. | June 6, 2025 | Election of Class I Directors: Michael Dybbs, Ph.D. | Director Elections | Board | WITHHOLD | 5 | |
| Taysha Gene Therapies, Inc. | June 2, 2025 | To elect the Board's Class II Director nominees, Phillip B. Donenberg, CPA and Sukumar Nagendran, MD to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Phillip B. Donenberg, CPA | Director Elections | Board | WITHHOLD | 5 | |
| Tenaya Therapeutics, Inc. | May 28, 2025 | To elect three Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: David Goeddel, Ph.D. | Director Elections | Board | WITHHOLD | 5 | |
| The E.W. Scripps Company | May 5, 2025 | Election of Directors: Kim Williams | Director Elections | Board | WITHHOLD | 5 | |
| The Trade Desk, Inc. | November 14, 2024 | The approval of the reincorporation of The Trade Desk, Inc. from the State of Delaware to the State of Nevada by conversion. | Extraordinary Transactions | Board | AGAINST | 5 | |
| The Trade Desk, Inc. | May 27, 2025 | The approval of The Trade Desk, Inc. 2025 Incentive Award Plan, which is an amendment and restatement of our 2016 Incentive Award Plan. | Compensation | Board | AGAINST | 5 | |
| Torrid Holdings Inc. | June 4, 2025 | DIRECTOR NOMINEES TO SERVE FOR A THREE-YEAR TERM EXPIRING AT THE FISCAL YEAR 2028 ANNUAL MEETING: Lisa M. Harper | Director Elections | Board | WITHHOLD | 5 | |
| Trip.com Group Limited | June 30, 2025 | Elect Rong Luo as Director | Director Elections | Board | AGAINST | 5 | |
| Under Armour, Inc. | September 4, 2024 | Election of Directors: Carolyn N. Everson | Director Elections | Board | WITHHOLD | 5 | |
| Under Armour, Inc. | September 4, 2024 | Election of Directors: Eric T. Olson | Director Elections | Board | WITHHOLD | 5 | |
| Under Armour, Inc. | September 4, 2024 | Election of Directors: Jerri L. DeVard | Director Elections | Board | WITHHOLD | 5 | |
| Under Armour, Inc. | September 4, 2024 | Election of Directors: Karen W. Katz | Director Elections | Board | WITHHOLD | 5 | |
| Under Armour, Inc. | September 4, 2024 | Election of Directors: Kevin A. Plank | Director Elections | Board | WITHHOLD | 5 | |
| iRobot Corporation | May 16, 2025 | Approve an amendment to the iRobot Corporation 2018 Stock Option and Incentive Plan, as amended (the "2018 Plan"), to increase the maximum number of shares reserved for issuance under the 2018 Plan. | Compensation | Board | AGAINST | 5 | |
| 1st Source Corporation | April 24, 2025 | Election of Directors for terms expiring April 2028: Daniel B. Fitzpatrick | Director Elections | Board | AGAINST | 4 | |
| 1st Source Corporation | April 24, 2025 | Election of Directors for terms expiring April 2028: John F. Affleck-Graves | Director Elections | Board | AGAINST | 4 | |
| 23andMe Holding Co. | August 26, 2024 | Elect two Class III Director Nominees: Anne Wojcicki | Director Elections | Board | WITHHOLD | 4 | |
| 23andMe Holding Co. | August 26, 2024 | Elect two Class III Director Nominees: Peter Taylor | Director Elections | Board | WITHHOLD | 4 | |
| 374Water Inc. | June 11, 2025 | Approval of certain amendments to the Company's 2021 Equity Incentive Plan to (i) increase the amount of authorized common stock of the Company issuable under the 2021 Equity Incentive Plan by 12,150,000 shares and (ii) increase the individual non-employee director compensation limit to $300,000 in any calendar year. | Compensation | Board | AGAINST | 4 | |
| 374Water Inc. | June 11, 2025 | Election of Directors: Deanna Rene Estes | Director Elections | Board | WITHHOLD | 4 | |
| 374Water Inc. | June 11, 2025 | Election of Directors: James M. Vanderhider | Director Elections | Board | WITHHOLD | 4 | |
| 89bio, Inc. | May 28, 2025 | Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D. | Director Elections | Board | WITHHOLD | 4 | |
| 908 Devices Inc. | June 12, 2025 | To elect three Class II directors to hold office until the 2028 annual meeting of stockholders: Kevin J. Knopp, Ph.D. | Director Elections | Board | WITHHOLD | 4 | |
| A10 Networks, Inc. | April 17, 2025 | To elect five directors to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. Braham | Director Elections | Board | WITHHOLD | 4 | |
| ACV Auctions Inc. | May 28, 2025 | Elect two Class I directors: George Chamoun | Director Elections | Board | WITHHOLD | 4 | |
| ACV Auctions Inc. | May 28, 2025 | Elect two Class I directors: Robert P. Goodman | Director Elections | Board | WITHHOLD | 4 | |
| ADC Therapeutics SA | November 11, 2024 | Approving amendments to Article 4a of the articles of association to increase the Company's capital range The Board of Directors proposes that the amendments to Article 4a of the articles of association to increase the Company's capital range be approved. | Capital Structure | Board | AGAINST | 4 | |
| ADC Therapeutics SA | November 11, 2024 | Approving amendments to Article 4c of the articles of association to Increase the Company's conditional share capital for financing, acquisitions and other purposes The Board of Directors proposes that the amendments to Article 4c of the articles of association to increase the Company's conditional share capital for financing, acquisitions and other purposes be approved. | Capital Structure | Board | AGAINST | 4 | |
| ADC Therapeutics SA | June 3, 2025 | Approving amendments to article 4b of the articles of association to increase the Company's conditional share capital for employee participation The Board of Directors is proposing that the amendments to article 4b paragraph 1 of the articles of association to increase the Company's conditional share capital for employee participation from 9,547,482 common shares (CHF 763,798.56) to 12,776,259 common shares (CHF 1,022,100.72) be approved, as follows (amendment underlined for ease of reference): "The share capital may be increased in an amount not to exceed CHF 1,022,100.72 through the issuance of up to 12,776,259 fully paid in registered shares with a par value of CHF 0.08 per share through the direct or indirect issuance of shares, or through the exercise or mandatory exercise of rights to acquire shares or through obligations to acquire shares, which were granted to or imposed on members of the Board of Directors, members of the executive management, employees, contractors or consultants of the Company or its group companies, or other persons providing services to the Company or its group companies." | Capital Structure | Board | AGAINST | 4 | |
| ADC Therapeutics SA | June 3, 2025 | Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Board of Directors is proposing that an amendment to increase the number of shares authorized under 2019 Equity Incentive Plan be approved. | Compensation | Board | AGAINST | 4 | |
| ADC Therapeutics SA | June 3, 2025 | Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for the period between the Annual Meeting and the 2026 annual general meeting of Shareholders be set at $2,300,000. | Compensation | Board | AGAINST | 4 | |
| AMC Networks Inc. | June 5, 2025 | Advisory vote on Named Executive Officer compensation | Say-on-Pay | Board | AGAINST | 4 | |
| AMC Networks Inc. | June 5, 2025 | Election of the following nominees as Directors: Carl E. Vogel | Director Elections | Board | WITHHOLD | 4 | |
| AMC Networks Inc. | June 5, 2025 | Election of the following nominees as Directors: Debra G. Perelman | Director Elections | Board | WITHHOLD | 4 | |
| AMC Networks Inc. | June 5, 2025 | Election of the following nominees as Directors: Joseph M. Cohen | Director Elections | Board | WITHHOLD | 4 | |
| AMC Networks Inc. | June 5, 2025 | Election of the following nominees as Directors: Leonard Tow | Director Elections | Board | WITHHOLD | 4 | |
| AMC Networks Inc. | June 5, 2025 | Election of the following nominees as Directors: Matthew C. Blank | Director Elections | Board | WITHHOLD | 4 | |
| AMC Networks Inc. | June 5, 2025 | Vote on Proposal to Approve the Company's Amended and Restated 2016 Employee Stock Plan | Compensation | Board | AGAINST | 4 | |
| AMC Networks Inc. | June 5, 2025 | Vote on Proposal to Approve the Company's Redomestication to the State of Nevada by Conversion | Extraordinary Transactions | Board | AGAINST | 4 | |
| ARS Pharmaceuticals, Inc. | June 25, 2025 | To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Richard Lowenthal | Director Elections | Board | WITHHOLD | 4 | |
| ASP Isotopes Inc. | November 20, 2024 | Approval of the Quantum Leap Energy LLC 2024 Equity Incentive Plan, as amended. | Compensation | Board | AGAINST | 4 | |
| ASP Isotopes Inc. | November 20, 2024 | Election of directors to serve as Class II directors for a three-year term: Duncan Moore, Ph.D. | Director Elections | Board | WITHHOLD | 4 | |
| ASP Isotopes Inc. | November 20, 2024 | Election of directors to serve as Class II directors for a three-year term: Michael Gorley, Ph.D. | Director Elections | Board | WITHHOLD | 4 | |
| AST Spacemobile, Inc. | September 10, 2024 | To approve the AST SpaceMobile, Inc. 2024 Incentive Award Plan. | Compensation | Board | AGAINST | 4 | |
| AVITA Medical, Inc. | June 4, 2025 | To approve (a) the 2020 Omnibus Incentive Plan Amended and Restated (the "Plan"), the terms of which are summarized in this Proxy Statement; and (b) for purposes of ASX Listing Rule 7.2 Exception 13(b), which provides an exception to ASX Listing Rule 7.1, the issuance of the Company's equity securities under the Plan, in accordance with its terms and conditions, for a period of up to three years from the date of stockholder approval. | Compensation | Board | AGAINST | 4 | |
| Achieve Life Sciences, Inc. | June 4, 2025 | To approve an amendment to our 2023 Non-Employee Director Equity Incentive Plan to increase the number of shares available for issuance thereunder. | Compensation | Board | AGAINST | 4 | |
| Acrivon Therapeutics, Inc. | June 13, 2025 | Election of Class III Directors: Derek DiRocco, Ph.D. | Director Elections | Board | WITHHOLD | 4 | |
| Acrivon Therapeutics, Inc. | June 13, 2025 | Election of Class III Directors: Santhosh Palani, Ph.D., C.F.A. | Director Elections | Board | WITHHOLD | 4 | |
| Acumen Pharmaceuticals, Inc. | June 4, 2025 | To elect three Class I directors, to the Board of Directors, each to hold office until the 2028 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: Kimberlee C. Drapkin | Director Elections | Board | WITHHOLD | 4 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: David Maher | Director Elections | Board | WITHHOLD | 4 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Ho Yeon (Aaron) Lee | Director Elections | Board | WITHHOLD | 4 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Keun Chang (Kevin) Yoon | Director Elections | Board | WITHHOLD | 4 | |
| Acushnet Holdings Corp. | June 2, 2025 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Director Elections | Board | WITHHOLD | 4 | |
| Adaptive Biotechnologies Corporation | June 10, 2025 | To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins | Director Elections | Board | WITHHOLD | 4 | |
| Advanced Flower Capital Inc. | May 19, 2025 | Election of Director: Robert Levy | Director Elections | Board | AGAINST | 4 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | Election of Class II Directors: James Scopa | Director Elections | Board | WITHHOLD | 4 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | Election of Class II Directors: Laurent Fischer, M.D. | Director Elections | Board | WITHHOLD | 4 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | Election of Class II Directors: Patrick Machado | Director Elections | Board | WITHHOLD | 4 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | To approve the amendment and restatement of the Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan. | Compensation | Board | AGAINST | 4 | |
| Adverum Biotechnologies, Inc. | June 17, 2025 | To approve the amendment of certain outstanding stock options to reduce the exercise price per share to the closing price on the date of repricing. | Compensation | Board | AGAINST | 4 | |
| AerSale Corporation | June 5, 2025 | To approve the Second Amendment to the AerSale Corporation 2020 Equity Incentive Plan; | Compensation | Board | AGAINST | 4 | |
| Aerovate Therapeutics, Inc. | April 16, 2025 | To approve the Jade Biosciences, Inc. 2025 Stock Incentive Plan (the "Stock Plan Proposal" or "Proposal No. 5"); | Compensation | Board | AGAINST | 4 | |
| Agenus Inc. | June 17, 2025 | To approve a one-time exchange modification of options to purchase shares under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan. | Compensation | Board | AGAINST | 4 | |
| Agenus Inc. | June 17, 2025 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares. | Compensation | Board | AGAINST | 4 | |
| Agenus Inc. | June 17, 2025 | To approve, in a non-binding advisory vote, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 4 | |
| Air Transport Services Group, Inc. | February 10, 2025 | To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger (the "Advisory Compensation Proposal"); and | Say-on-Pay | Board | AGAINST | 4 | |
| AirSculpt Technologies, Inc. | May 7, 2025 | Election of Directors: Dan Sollof | Director Elections | Board | AGAINST | 4 | |
| AirSculpt Technologies, Inc. | May 7, 2025 | Election of Directors: Yogesh Jashnani | Director Elections | Board | AGAINST | 4 | |
| Airship AI Holdings, Inc. | December 13, 2024 | Election of Directors: Peeyush Ranjan | Director Elections | Board | WITHHOLD | 4 | |
| Akero Therapeutics, Inc. | June 3, 2025 | To elect two class III directors, Judy Chou, Ph.D. and Tomas Heyman, to our board of directors, to serve until the 2028 Annual Meeting of stockholders and until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal: Judy Chou, Ph.D. | Director Elections | Board | WITHHOLD | 4 | |
| AlTi Global, Inc. | June 16, 2025 | To approve an amendment to the Company's 2023 Stock Incentive Plan to increase the number of shares of Class A Common Stock available for issuance under the Company's 2023 Stock Incentive Plan and the number of shares that may be issued pursuant to incentive stock options by an additional 9,010,000 shares. | Compensation | Board | AGAINST | 4 | |
| Alarm.com Holdings, Inc. | June 4, 2025 | To approve the Alarm.com Holdings, Inc. 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 4 | |
| Alerus Financial Corporation | May 8, 2025 | Election of Directors: John Uribe | Director Elections | Board | WITHHOLD | 4 | |
| Alerus Financial Corporation | May 8, 2025 | Election of Directors: Randy L. Newman | Director Elections | Board | WITHHOLD | 4 | |
| Alexander's, Inc. | May 22, 2025 | Election of Directors: Steven Roth | Director Elections | Board | WITHHOLD | 4 | |
| Alico, Inc. | February 28, 2025 | Approval of the amendment and restatement of the Alico, Inc. Stock Incentive Plan of 2015. | Compensation | Board | AGAINST | 4 | |
| Alight, Inc. | July 2, 2024 | To elect four Class III director nominees to our Board of Directors: William P. Foley, II | Director Elections | Board | WITHHOLD | 4 | |
| Alight, Inc. | June 4, 2025 | To elect four Class I director nominees to our Board of Directors: Kausik Rajgopal | Director Elections | Board | WITHHOLD | 4 | |
| Alignment Healthcare, Inc. | June 5, 2025 | Election of Directors: Mark McClellan | Director Elections | Board | WITHHOLD | 4 | |
| Alimera Sciences, Inc. | September 4, 2024 | To approve, by non-binding, advisory vote, the compensation that will or may be paid or become payable to our named executive officers that is based on or otherwise relates to the Merger. | Say-on-Pay | Board | AGAINST | 4 | |
| Alphatec Holdings, Inc. | June 11, 2025 | Approval of an amendment to our 2016 Equity Incentive Plan. | Compensation | Board | AGAINST | 4 | |
| Alpine Income Property Trust, Inc. | May 21, 2025 | Advisory vote to approve executive compensation | Say-on-Pay | Board | AGAINST | 4 | |
| Alta Equipment Group Inc. | May 30, 2025 | Election of Directors: Daniel Shribman | Director Elections | Board | WITHHOLD | 4 | |
| Alta Equipment Group Inc. | May 30, 2025 | Election of Directors: Katherine E. White | Director Elections | Board | WITHHOLD | 4 | |
| Altimmune, Inc. | September 26, 2024 | Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. | Say-on-Pay | Board | AGAINST | 4 | |
| Alto Neuroscience, Inc. | May 13, 2025 | To elect the Board's Class I Director nominee, Husseini Manji, to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Husseini Manji | Director Elections | Board | WITHHOLD | 4 | |
| American Assets Trust, Inc. | June 2, 2025 | Election of Directors: Joy L. Schaefer | Director Elections | Board | WITHHOLD | 4 | |
| American Assets Trust, Inc. | June 2, 2025 | Election of Directors: Nina A. Tran | Director Elections | Board | WITHHOLD | 4 | |
| American Assets Trust, Inc. | June 2, 2025 | Election of Directors: Robert S. Sullivan | Director Elections | Board | WITHHOLD | 4 | |
| American Realty Investors, Inc. | December 11, 2024 | Election of Directors: Fernando Victor Lara Celis | Director Elections | Board | WITHHOLD | 4 | |
| American Realty Investors, Inc. | December 11, 2024 | Election of Directors: Robert A. Jakuszewski | Director Elections | Board | WITHHOLD | 4 | |
| Amneal Pharmaceuticals, Inc. | May 6, 2025 | Election of Directors: Paul Meister | Director Elections | Board | AGAINST | 4 | |
| Amprius Technologies, Inc. | June 12, 2025 | Election of Class III Directors: Donald R. Dixon | Director Elections | Board | WITHHOLD | 4 | |
| Amprius Technologies, Inc. | June 12, 2025 | Election of Class III Directors: Dr. Kang Sun | Director Elections | Board | WITHHOLD | 4 | |
| AnaptysBio, Inc. | June 17, 2025 | To approve an amendment to our 2017 Equity Incentive Plan. | Compensation | Board | AGAINST | 4 | |
| AnaptysBio, Inc. | June 17, 2025 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. | Say-on-Pay | Board | AGAINST | 4 | |
| Anavex Life Sciences Corp. | June 10, 2025 | To approve an amendment to the Company's 2022 Omnibus Incentive Plan. | Compensation | Board | AGAINST | 4 | |
| Antero Midstream Corporation | June 4, 2025 | Class III Nominees: David H. Keyte | Director Elections | Board | WITHHOLD | 4 |
← Previous Page 8 of 25 Next →
← Back to Guggenheim 2024-2025 overview
Built October 25, 2026 from SEC Form N-PX filings.